NCT03504046View on ClinicalTrials.gov

Safety and Feasibility Evaluation of the APS APP

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

September 4, 2018

Study Completion Date

September 4, 2018

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas App

The portable Artificial Pancreas System App (APS APP) is an artificial pancreas system comprised primarily of an insulin pump, a continuous glucose monitor (CGM), and a cellular phone device to connect the components.

Trial Locations (1)

93105

Sansum Diabetes Research Institute, Santa Barbara

All Listed Sponsors
collaborator

Harvard University

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT03504046 - Safety and Feasibility Evaluation of the APS APP | Biotech Hunter | Biotech Hunter